Have Insiders Sold Guardant Health Shares Recently?

We wouldn't blame Guardant Health, Inc. (NASDAQ:GH) shareholders if they were a little worried about the fact that Helmy Eltoukhy, the Co-Founder recently netted about US$18m selling shares at an average price of US$59.45. That sale reduced their total holding by 11% which is hardly insignificant, but far from the worst we've seen.

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

Guardant Health Insider Transactions Over The Last Year

In fact, the recent sale by Helmy Eltoukhy was the biggest sale of Guardant Health shares made by an insider individual in the last twelve months, according to our records. So what is clear is that an insider saw fit to sell at around the current price of US$54.90. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern.

In the last year Guardant Health insiders didn't buy any company stock. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

See our latest analysis for Guardant Health

For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.

Insider Ownership Of Guardant Health

Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Guardant Health insiders own about US$266m worth of shares (which is 3.9% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

So What Does This Data Suggest About Guardant Health Insiders?

Insiders sold Guardant Health shares recently, but they didn't buy any. And even if we look at the last year, we didn't see any purchases. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. At Simply Wall St, we've found that Guardant Health has 3 warning signs (1 can't be ignored!) that deserve your attention before going any further with your analysis.

Of course Guardant Health may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.